Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia.
Cheng S, Fleres G, Chen L, Liu G, Hao B, Newbrough A, Driscoll E, Shields RK, Squires KM, Chu TY, Kreiswirth BN, Nguyen MH, Clancy CJ. Cheng S, et al. Among authors: squires km. mBio. 2022 Dec 20;13(6):e0290622. doi: 10.1128/mbio.02906-22. Epub 2022 Nov 29. mBio. 2022. PMID: 36445082 Free PMC article.
Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producing K. pneumoniae clinical isolates.
Rogers TM, Kline EG, Griffith MP, Jones CE, Rubio AM, Squires KM, Shields RK. Rogers TM, et al. Among authors: squires km. JAC Antimicrob Resist. 2023 Mar 23;5(2):dlad022. doi: 10.1093/jacamr/dlad022. eCollection 2023 Apr. JAC Antimicrob Resist. 2023. PMID: 36968951 Free PMC article.
Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae.
Rogers TM, Kline EG, Griffith MP, Jones CE, Rubio AM, Squires KM, Shields RK. Rogers TM, et al. Among authors: squires km. JAC Antimicrob Resist. 2023 Oct 26;5(5):dlad113. doi: 10.1093/jacamr/dlad113. eCollection 2023 Oct. JAC Antimicrob Resist. 2023. PMID: 37901589 Free PMC article.
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
Westbrook KJ, Chilambi GS, Stellfox ME, Nordstrom HR, Li Y, Iovleva A, Shah NH, Jones CE, Kline EG, Squires KM, Miller WR, Tran TT, Arias CA, Doi Y, Shields RK, Van Tyne D. Westbrook KJ, et al. Among authors: squires km. J Antimicrob Chemother. 2024 Apr 2;79(4):801-809. doi: 10.1093/jac/dkae032. J Antimicrob Chemother. 2024. PMID: 38334390
Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections.
Shields RK, Dorazio AJ, Tiseo G, Squires KM, Leonildi A, Giordano C, Kline EG, Barnini S, Iovleva A, Griffith MP, Van Tyne D, Doi Y, Falcone M. Shields RK, et al. Among authors: squires km. JAC Antimicrob Resist. 2024 Sep 9;6(5):dlae146. doi: 10.1093/jacamr/dlae146. eCollection 2024 Oct. JAC Antimicrob Resist. 2024. PMID: 39253335 Free PMC article.
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.
Demeter LM, Bosch RJ, Coombs RW, Fiscus S, Bremer J, Johnson VA, Erice A, Jackson JB, Spector SA, Squires KM, Fischl MA, Hughes MD, Hammer SM. Demeter LM, et al. Among authors: squires km. J Clin Microbiol. 2002 Jun;40(6):2089-94. doi: 10.1128/JCM.40.6.2089-2094.2002. J Clin Microbiol. 2002. PMID: 12037070 Free PMC article. Clinical Trial.